𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Importance of the treatment package time in surgery and postoperative radiation therapy for squamous carcinoma of the head and neck

✍ Scribed by David I. Rosenthal; Li Liu; Jason H. Lee; Neha Vapiwala; Ara A. Chalian; Gregory S. Weinstein; Irina Chilian; Randal S. Weber; Mitchell Machtay


Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
194 KB
Volume
24
Category
Article
ISSN
1043-3074

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Background

To determine the effect of treatment time‐related factors on outcome in patients treated with surgery and postoperative radiation therapy (RT) for locally advanced squamous cell carcinoma of head and neck (SCCHN)

Methods

A retrospective review was performed on 208 consecutive patients treated from 1992 to 1997 with surgery and postoperative RT (β‰₯55 Gy) for SCCHN. The treatment time factors considered were (1) interval from surgery to the start of RT; (2) RT duration; and (3) the total time from surgery to completion of RT (treatment package time). Treatment package time was dichotomized into short (≀100 days) vs long (>100 days) categories. Other variables considered were clinical and pathologic staging, margin status, RT dose, and tumor site. Patients were also divided into intermediate‐ and high‐risk groups on the basis of eligibility for RTOG 95‐01. Univariate (logrank) and multivariate analyses were performed.

Results

Median follow‐up for surviving patients was 24 months. Actuarial 2‐year locoregional control (LRC) and survival rates were 82% and 71%, respectively. In univariate analysis, factors associated with higher locoregional failure were high‐risk group (p = .011), margin status (p = .038), pathologic stage (p = .035), clinical N stage (p = .006), package time (p = .013), and RT treatment time (p = .03). Package time was also a significant predictor of survival in univariate analysis (p = .021). The other two individual time factors, tumor factors, and RT dose were not significant. Both risk status and treatment package time were significant factors in a multivariate model of LRC.

Conclusions

A total treatment package time of <100 days is associated with improved tumor control and survival. Every effort should be made to keep the time from surgery to the completion of postoperative RT to <100 days. Β© 2002 John Wiley & Sons, Inc.


πŸ“œ SIMILAR VOLUMES


Postoperative radiation therapy for prim
✍ William F. Regine; Joseph Valentino; David A. Sloan; Pushpa Patel; Melissa Q. Pi πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 91 KB πŸ‘ 2 views

Background. There is little literature comparatively evaluating the results of postoperative radiation therapy (RT) for patients with squamous cell carcinoma (SCC) of the head and neck treated for primary versus recurrent disease. Methods. Between 1981 and 1993, 174 patients with SCC of the head an

Targeted therapies in squamous cell carc
✍ Kathryn A. Gold; Ho-Young Lee; Edward S. Kim πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 170 KB πŸ‘ 3 views

## Abstract Head and neck cancer is a challenging disease that is expected to account for greater than 500,000 new cases worldwide in 2008. Toxicity has impeded advances in chemotherapy and radiation for head and neck cancer, and the prognosis for patients with recurrent and/or metastatic disease r

Treatment of the N0 neck during salvage
✍ Stephane Temam; Venkata Koka; GΓ©rard Mamelle; Morbize Julieron; Romain Carmantra πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 88 KB πŸ‘ 2 views

Background. The morbidity and mortality rates of salvage surgery in patients with local recurrence of head and neck squamous cell carcinoma (HNSCC) after radiotherapy are high. The aim of this study was to determine the rate of occult neck node metastasis and the surgical morbidity of patients after

Bioreductive alkylating agent porfiromyc
✍ Bruce G. Haffty; Yung H. Son; Lynn D. Wilson; Rose Papac; Diana Fischer; Sara Ro πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 141 KB πŸ‘ 3 views

Porfiromycin (methyl mitomycin C) has been shown in laboratory studies to have increased preferential cytotoxicity to hypoxic cells and therefore may provide enhanced therapeutic efficacy over mitomycin C when used in combination with radiation therapy (RT). The purpose of the two clinical studies r